These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 39018872)

  • 1. Podocyte programmed cell death in diabetic kidney disease: Molecular mechanisms and therapeutic prospects.
    Yang H; Sun J; Sun A; Wei Y; Xie W; Xie P; Zhang L; Zhao L; Huang Y
    Biomed Pharmacother; 2024 Aug; 177():117140. PubMed ID: 39018872
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Podocyte Death in Diabetic Kidney Disease: Potential Molecular Mechanisms and Therapeutic Targets.
    Zhong S; Wang N; Zhang C
    Int J Mol Sci; 2024 Aug; 25(16):. PubMed ID: 39201721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modes of podocyte death in diabetic kidney disease: an update.
    Jiang A; Song A; Zhang C
    J Nephrol; 2022 Jul; 35(6):1571-1584. PubMed ID: 35201595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Research progress on multiple cell death pathways of podocytes in diabetic kidney disease.
    Yang C; Zhang Z; Liu J; Chen P; Li J; Shu H; Chu Y; Li L
    Mol Med; 2023 Oct; 29(1):135. PubMed ID: 37828444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. JAK/STAT pathway promotes the progression of diabetic kidney disease via autophagy in podocytes.
    Chen D; Liu Y; Chen J; Lin H; Guo H; Wu Y; Xu Y; Zhou Y; Zhou W; Lu R; Zhou J; Wu J
    Eur J Pharmacol; 2021 Jul; 902():174121. PubMed ID: 33901462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Podocyte Injury in Diabetic Kidney Disease in Mouse Models Involves TRPC6-mediated Calpain Activation Impairing Autophagy.
    Salemkour Y; Yildiz D; Dionet L; 't Hart DC; Verheijden KAT; Saito R; Mahtal N; Delbet JD; Letavernier E; Rabant M; Karras A; van der Vlag J; Nijenhuis T; Tharaux PL; Lenoir O
    J Am Soc Nephrol; 2023 Nov; 34(11):1823-1842. PubMed ID: 37678257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MYDGF attenuates podocyte injury and proteinuria by activating Akt/BAD signal pathway in mice with diabetic kidney disease.
    He M; Li Y; Wang L; Guo B; Mei W; Zhu B; Zhang J; Ding Y; Meng B; Zhang L; Xiang L; Dong J; Liu M; Xiang L; Xiang G
    Diabetologia; 2020 Sep; 63(9):1916-1931. PubMed ID: 32588068
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p66Shc regulates podocyte autophagy in high glucose environment through the Notch-PTEN-PI3K/Akt/mTOR pathway.
    Zheng D; Tao M; Liang X; Li Y; Jin J; He Q
    Histol Histopathol; 2020 Apr; 35(4):405-415. PubMed ID: 31650524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The role of podocyte autophagy and endoplasmic reticulum stress in diabetic kidney disease].
    Li R; Guo Z
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2022 Feb; 34(2):221-224. PubMed ID: 35387735
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Wogonin protects glomerular podocytes by targeting Bcl-2-mediated autophagy and apoptosis in diabetic kidney disease.
    Liu XQ; Jiang L; Li YY; Huang YB; Hu XR; Zhu W; Wang X; Wu YG; Meng XM; Qi XM
    Acta Pharmacol Sin; 2022 Jan; 43(1):96-110. PubMed ID: 34253875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tripterygium glycoside protects diabetic kidney disease mouse serum-induced podocyte injury by upregulating autophagy and downregulating β-arrestin-1.
    Zhan H; Jin J; Liang S; Zhao L; Gong J; He Q
    Histol Histopathol; 2019 Aug; 34(8):943-952. PubMed ID: 30839094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Research Progress on the Pathological Mechanisms of Podocytes in Diabetic Nephropathy.
    Zhang L; Wen Z; Han L; Zheng Y; Wei Y; Wang X; Wang Q; Fang X; Zhao L; Tong X
    J Diabetes Res; 2020; 2020():7504798. PubMed ID: 32695831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Research advance in the mechanism for oxidative stress-induced podocyte injury in diabetic kidney disease.
    Ao L; Xie Y
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2021 Dec; 46(12):1403-1408. PubMed ID: 35232911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of PCSK9 in glomerular lipid accumulation and renal injury in diabetic kidney disease.
    Wu M; Yoon CY; Park J; Kim G; Nam BY; Kim S; Park JT; Han SH; Kang SW; Yoo TH
    Diabetologia; 2024 Sep; 67(9):1980-1997. PubMed ID: 38879617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deficiency of Nuclear Receptor Coactivator 3 Aggravates Diabetic Kidney Disease by Impairing Podocyte Autophagy.
    Xie Y; Yuan Q; Cao X; Qiu Y; Zeng J; Cao Y; Xie Y; Meng X; Huang K; Yi F; Zhang C
    Adv Sci (Weinh); 2024 May; 11(19):e2308378. PubMed ID: 38483947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanism of progression of diabetic kidney disease mediated by podocyte mitochondrial injury.
    Su J; Ye D; Gao C; Huang Q; Gui D
    Mol Biol Rep; 2020 Oct; 47(10):8023-8035. PubMed ID: 32918716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IGFBP-1 expression is reduced in human type 2 diabetic glomeruli and modulates β1-integrin/FAK signalling in human podocytes.
    Lay AC; Hale LJ; Stowell-Connolly H; Pope RJP; Nair V; Ju W; Marquez E; Rollason R; Hurcombe JA; Hayes B; Roberts T; Gillam L; Allington J; Nelson RG; Kretzler M; Holly JMP; Perks CM; McArdle CA; Welsh GI; Coward RJM
    Diabetologia; 2021 Jul; 64(7):1690-1702. PubMed ID: 33758952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tripterygium glycoside suppresses epithelial‑to‑mesenchymal transition of diabetic kidney disease podocytes by targeting autophagy through the mTOR/Twist1 pathway.
    Tao M; Zheng D; Liang X; Wu D; Hu K; Jin J; He Q
    Mol Med Rep; 2021 Aug; 24(2):. PubMed ID: 34165172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Paeoniflorin binds to VEGFR2 to restore autophagy and inhibit apoptosis for podocyte protection in diabetic kidney disease through PI3K-AKT signaling pathway.
    Wang X; Jiang L; Liu XQ; Huang YB; Wang AL; Zeng HX; Gao L; Zhu QJ; Xia LL; Wu YG
    Phytomedicine; 2022 Nov; 106():154400. PubMed ID: 36049428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CCDC92 deficiency ameliorates podocyte lipotoxicity in diabetic kidney disease.
    Zuo F; Wang Y; Xu X; Ding R; Tang W; Sun Y; Wang X; Zhang Y; Wu J; Xie Y; Liu M; Wang Z; Yi F
    Metabolism; 2024 Jan; 150():155724. PubMed ID: 37952690
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.